Drugs / LEO 39652
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02219633 | Jul → Dec 2014 | atopic eczema | LEO Pharma | Completed | No outcome recorded |
| Phase 1 | NCT01850849 | May 2013 → Nov 2014 | atopic eczema | LEO Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LEO 39652 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02219633 ↗ |
| Route | Topical | “LEO 39652 cream is administered cutaneously as single dose” NCT01850849 ↗ |